Serum Cytokine Profiles As Biomarker In Multi-Drug Resistant Tuberculosis (MDR-TB).

作者: A.N. Boakye

DOI:

关键词: Multi-drug-resistant tuberculosisImmunologyBiomarker (medicine)Serum cytokineMedicine

摘要:

参考文章(74)
I M Orme, E R Rhoades, A M Cooper, D M Getzy, J E Callahan, A D Roberts, THE ROLE OF INTERLEUKIN-12 IN ACQUIRED IMMUNITY TO MYCOBACTERIUM TUBERCULOSIS INFECTION Immunology. ,vol. 84, pp. 423- 432 ,(1995)
Françoise Portaels, I Bastian, Krista Fissette, Hamidou Traore, Michel Devleeschouwer, Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. International Journal of Tuberculosis and Lung Disease. ,vol. 4, pp. 481- 484 ,(2000)
Rukhsana Anwar, Saadia Ashraf, Naveed Khan, Mukhtiar Zaman Afridi, Fazli Wahab, Risk factors for multi-drug resistant tuberculosis in patients at tertiary care hospital, Peshawar. Jcpsp-journal of The College of Physicians and Surgeons Pakistan. ,vol. 19, pp. 162- 164 ,(2009)
Neil W Schluger, Recent advances in our understanding of human host responses to tuberculosis Respiratory Research. ,vol. 2, pp. 157- 163 ,(2001) , 10.1186/RR53
A Maulu, J Nash, VG Fredlund, TK Hartung, Suspected pulmonary tuberculosis in rural South Africa--sputum induction as a simple diagnostic tool? South African Medical Journal. ,vol. 92, pp. 455- 458 ,(2002)
Anca Dorhoi, Vladimir Yeremeev, Geraldine Nouailles, January Weiner, Sabine Jörg, Ellen Heinemann, Dagmar Oberbeck‐Müller, Julia K. Knaul, Alexis Vogelzang, Stephen T. Reece, Karin Hahnke, Hans‐Joachim Mollenkopf, Volker Brinkmann, Stefan H. E. Kaufmann, Type I IFN signaling triggers immunopathology in tuberculosis‐susceptible mice by modulating lung phagocyte dynamics European Journal of Immunology. ,vol. 44, pp. 2380- 2393 ,(2014) , 10.1002/EJI.201344219
N McCartney-Francis, S M Wahl, L M Wahl, A B Roberts, S Dougherty, G Hall, J A Schmidt, D A Hunt, H L Wong, L Ellingsworth, Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. Journal of Immunology. ,vol. 140, pp. 3026- 3032 ,(1988)
I. Wergeland, J. Aßmus, A. M. Dyrhol-Riise, T Regulatory Cells and Immune Activation in Mycobacterium tuberculosis Infection and the Effect of Preventive Therapy Scandinavian Journal of Immunology. ,vol. 73, pp. 234- 242 ,(2011) , 10.1111/J.1365-3083.2010.02496.X
T K VanHeyningen, D G Russell, H L Collins, IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses. Journal of Immunology. ,vol. 158, pp. 330- 337 ,(1997)
J. Harris, J. Keane, How tumour necrosis factor blockers interfere with tuberculosis immunity. Clinical and Experimental Immunology. ,vol. 161, pp. 1- 9 ,(2010) , 10.1111/J.1365-2249.2010.04146.X